Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-22

Clinical Trial Update: Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection [NA]

View source ↗

Summary

This clinical trial update notes that a study evaluating the additive effect of Endonase on eradication rates for second-line Helicobacter pylori therapy has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endonase

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Helicobacter Pylori Infection | NA | Status: TERMINATED